Sorry, you need to enable JavaScript to visit this website.

Making sure that medicines are accessible and affordable for patients is a goal we all share. But the dangerous policy outlined in H.R. 3 could threaten the future of groundbreaking cures.

The policy would allow government “negotiations” on the price of medicines for Medicare. Moreover, this misguided policy would repeal a key provision of the Medicare Part D program – the noninterference clause – that protects coverage and access to medicines for seniors and people with disabilities. Taking away this protection threatens patients’ access to medicines and sacrifices future medical advances.

There are major problems with H.R. 3:

Adopting H.R. 3 could result in serious consequences for patients and the U.S. healthcare system. To lower healthcare costs, you should reject government “negotiation” policies and support real solutions to make medicines more affordable and accessible, such as capping annual out-of-pocket costs in Part D.